老年肾衰竭患者接受慢性透析前三年生存优于非透析治疗
该回顾性队列研究纳入加拿大阿尔伯塔省2002-2012年838例65岁以上肾衰竭患者(平均年龄79.1岁,平均eGFR 7.8 mL/min/1.73m2),采用边际结构Cox模型比较透析与非透析的全因死亡风险。结果显示透析与随访前三年死亡风险显著降低相关(HR 0.59,95%CI 0.46-0.77),但三年后无显著差异(HR 1.22,95%CI 0.69-2.17),且透析与住院风险显著升高相关(HR 1.40,95%CI 1.16-1.69)。
要点
- 老年肾衰竭患者透析前三年死亡风险显著低于非透析(HR 0.59,95%CI 0.46-0.77)。
- 透析三年后生存获益不再显著(HR 1.22,95%CI 0.69-2.17)。
- 透析与住院风险显著升高相关(HR 1.40,95%CI 1.16-1.69)。
核心结论
- 老年肾衰竭患者接受透析与三年内生存延长相关,但住院风险更高。
研究设计与样本
- 回顾性队列研究,利用加拿大阿尔伯塔省关联行政与实验室数据,纳入2002-2012年838例65岁以上肾衰竭患者。
主要发现
- 透析与非透析相比,前三年全因死亡风险显著降低(HR 0.59,95%CI 0.46-0.77)。
- 三年后透析与非透析的死亡风险无显著差异(HR 1.22,95%CI 0.69-2.17)。
- 透析与显著更高的住院风险相关(HR 1.40,95%CI 1.16-1.69)。
关键数值与推荐
- 肾衰竭定义为连续两次或以上门诊eGFR低于10 mL/min/1.73m2且间隔90天以上。
- 纳入患者平均年龄79.1岁,48.6%为男性,平均eGFR 7.8 mL/min/1.73m2。
临床怎么用
- 研究结果可用于老年肾衰竭患者透析与非透析治疗的共享决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Comparisons of survival between dialysis and nondialysis care for older adults with kidney failure have been limited to those managed by nephrologists, and are vulnerable to lead and immortal time biases. So we compared time to all-cause mortality among older adults with kidney failure treated vs. not treated with chronic dialysis. Our retrospective cohort study used linked administrative and laboratory data to identify adults aged 65 or more years of age in Alberta, Canada, with kidney failure (2002-2012), defined by two or more consecutive outpatient estimated glomerular filtration rates less than 10 mL/min/1.73m2, spanning 90 or more days. We used marginal structural Cox models to assess the association between receipt of dialysis and all-cause mortality by allowing control for both time-varying and baseline confounders. Overall, 838 patients met inclusion criteria (mean age 79.1; 48.6% male; mean estimated glomerular filtration rate 7.8 mL/min/1.73m2). Dialysis treatment (vs. no dialysis) was associated with a significantly lower risk of death for the first three years of follow-up (hazard ratio 0.59 [95% confidence interval 0.46-0.77]), but not thereafter (1.22 [0.69-2.17]). However, dialysis was associated with a significantly higher risk of hospitalization (1.40 [1.16-1.69]). Thus, among older adults with kidney failure, treatment with dialysis was associated with longer survival up to three years after reaching kidney failure, though with a higher risk of hospital admissions. These findings may assist shared decision-making about treatment of kidney failure.
引用
- Tam-Tham H, Quinn RR, Weaver RG, et al. Survival among older adults with kidney failure is better in the first three years with chronic dialysis treatment than not. Kidney Int. 2018. PMID: 29803405. doi:10.1016/j.kint.2018.03.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。